Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo.
Toshiyuki Yoneda(The University of Osaka), Gregory R. Mundy(The University of Texas at San Antonio Health Science Center), Elżbieta Izbicka(The University of Texas at San Antonio Health Science Center), Chul‐Ho Lee(Korea University), Y Uehara(National Institute of Infectious Diseases), Maria Niewolna(The University of Texas at San Antonio Health Science Center), G. Gutierrez(Oblate School of Theology), Carolyn Lowe(The University of Texas at San Antonio Health Science Center), Paul J. Williams(Texas A&M University)
Cited by 89
Related Papers
Stimulation of Bone Formation in Vitro and in Rodents by Statins
|Science|1999|1.8k
BMP2 Regulates Osterix through Msx2 and Runx2 during Osteoblast Differentiation
|Journal of Biological Chemistry|2008|529
Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation
|Journal of Clinical Investigation|2004|417
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
|Journal of Clinical Oncology|1998|366